Camlin Fine Sciences’ shares have jumped due to anti-dumping duties on Chinese manufacturers by the US and EU, benefiting its aroma exports, particularly vanillin. The company plans to increase vanillin capacity utilization, aiming for higher revenue and improved EBITDA margins. Brokerages have raised valuations, citing growth potential and a better debt position, leading to a significant stock increase.
$20 billion of IPOs per year a new normal for India: JP Morgan
Initial public offerings worth USD 20 billion per annum are the “new normal” for India and will become an annualised run rate over the next